Special Issue "Mucocutaneous Manifestations of HIV after 40 Years from the First Case"
Deadline for manuscript submissions: 31 December 2021.
Interests: oral diseases; oral health; bioactive phytochemicals; biomaterials; nanomaterials; drug delivery systems
Special Issues and Collections in MDPI journals
Special Issue in Antibiotics: Antimicrobial Plant Extracts and Phytochemicals
Special Issue in Vaccines: Immunomodulatory Plants & Plant-Derived Immunomodulators
Special Issue in Antibiotics: Antimicrobial Agents in Oral Diseases: Prophylaxis and Therapy between New and Old Molecules
Special Issue in International Journal of Molecular Sciences: Flavonoids
Special Issue in Antibiotics: Antimicrobial Plant Extracts and Phytochemicals, 2nd Volume
The year 1991 represents a crucial year for the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS) epidemic. In June of that year, the Center for Disease Control (CDC) reported two clusters of rare diseases, Pneumocystis carinii pneumonia and Kaposi’s Sarcoma, respectively, which mostly affected gay American men, previously healthy.
Since then, the scientific community has been tirelessly devoted to investigating etiopathogenesis, diagnosis, prevention and treatment, achieving important successes.
Most patients show at least one mucocutaneous HIV/AIDS-related manifestation in their clinical history; it often occurs at the early onset of the infection and correlates with the immunologic stage and the use of highly active antiretroviral therapy (HAART).
Efforts towards new, additional therapies and preventive strategies are now underway, following the important recent discoveries on AIDS pathogenesis. These therapies have outcomes on oral and cutaneous disorders, emphasizing the need for a multidisciplinary approach to these patients.
We kindly invite clinical and basic researchers to submit original research, review or expert opinion articles about pathogenesis, diagnosis and treatment of HIV/AIDS, with a particular focus on skin and oral disorders.
Prof. Dr. Elena Maria Varoni
Prof. Dr. Giovanni Lodi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- muco-cutaneous diseases
- oral diseases
- acquired immunodeficiency
- HIV vaccine
- Kaposi’s Sarcoma
- human papillomavirus
- anti-retroviral therapy